Unknown

Dataset Information

0

Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.


ABSTRACT: To assess morning stiffness in rheumatoid arthritis (RA) patients switched from immediate-release (IR) to delayed-release (DR) prednisone.Circadian Administration of Prednisone in Rheumatoid Arthritis-1 (CAPRA-1) is a 12-week, randomized, multicentre, active-controlled study of morning stiffness that consisted of a double-blind phase and a 9-month open-label extension. Patients receiving IR prednisone with no significant improvement after the double-blind study were switched to DR prednisone. Morning stiffness duration and median absolute and relative changes in pain and global assessment were evaluated (3, 6, and 9 months).In patients switched from IR to DR prednisone (n=110), statistically significant reductions in morning stiffness occurred over 3 months and were sustained for 9 months. Absolute reduction of morning stiffness was ~50 min with >40% relative reduction at each visit. Interleukin (IL)-6 levels were reduced by the same amount. Statistically significant and clinically meaningful mean reductions in morning stiffness were maintained at >67 min at each visit along with significant improvements in pain and patient global assessment. There was no evidence of tachyphylaxis seen over the 9-month study.Patients receiving disease-modifying anti-rheumatic drugs (DMARDs) and IR prednisone who had not had significant reductions in morning stiffness demonstrated statistically significant and clinically meaningful improvements when switched to DR prednisone.

SUBMITTER: Alten R 

PROVIDER: S-EPMC4732433 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.

Alten R R   Holt R R   Grahn A A   Rice P P   Kent J J   Buttgereit F F   Gibofsky A A  

Scandinavian journal of rheumatology 20150626 5


<h4>Objective</h4>To assess morning stiffness in rheumatoid arthritis (RA) patients switched from immediate-release (IR) to delayed-release (DR) prednisone.<h4>Method</h4>Circadian Administration of Prednisone in Rheumatoid Arthritis-1 (CAPRA-1) is a 12-week, randomized, multicentre, active-controlled study of morning stiffness that consisted of a double-blind phase and a 9-month open-label extension. Patients receiving IR prednisone with no significant improvement after the double-blind study w  ...[more]

Similar Datasets

| S-EPMC5696287 | biostudies-literature
| S-EPMC10290342 | biostudies-literature
| S-EPMC6521890 | biostudies-literature
| S-EPMC4876147 | biostudies-literature
| S-EPMC8785267 | biostudies-literature
| S-EPMC5966898 | biostudies-literature
2021-05-01 | GSE173622 | GEO
| S-EPMC8188899 | biostudies-literature
| S-EPMC4674988 | biostudies-literature
| S-EPMC2039722 | biostudies-literature